Easily Send & Share Press Releases

(800) 307-6627
About Contact Us
Register Sign In
Tap to Toggle Navigation Menu
  • Newsroom
  • Pricing
  • Send Releases
    • Self Service Publishing
    • Full Service Publishing
    • Distribution Options
    • Reporting & Analysis
    • Search Engine Optimization
  • Send Releases
  • Regulatory Filings
  • NASDAQ OMX Media Suite
  • Learning & Support
    • Reader Support
    • Customer Support
    • Knowledge Base Archives
  • Learning & Support
Search Results

Organization: (Aegerion Pharmaceuticals, Inc. OR Aegerion Pharmaceuticals, Inc.)

If you make changes to this saved search, you'll find the original and new searches in your account.

Your search filters:

Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc.

Narrow by:

Organization
Industry
  • Show Top 5

Subject
  • Show All

  • Show Top 5

Tag
  • Show More

  • Show Top 5

Date Published





Language
  • Show Top 5

Country
  • Show Top 5

State/Province
  • Show Top 5

Showing 1-10 of about 100 articles.

  • 1
  • 2
  • ...
  • 10
  • Next »
Aegerion Pharmaceuticals, Inc. Logo

Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces Webcast of Investor Presentations at Upcoming Conferences

CAMBRIDGE, Mass., May 24, 2013 (GLOBE NEWSWIRE) --

about 1 day ago 

Aegerion Pharmaceuticals, Inc. Logo

Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program

CAMBRIDGE, Mass., May 3, 2013 (GLOBE NEWSWIRE) --

about 21 days ago 

Aegerion Pharmaceuticals, Inc. Logo

Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces Presentation at the Bank of America Merrill Lynch 2013 Healthcare Conference

CAMBRIDGE, Mass., May 3, 2013 (GLOBE NEWSWIRE) --

about 22 days ago 

Aegerion Pharmaceuticals, Inc. Logo

Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces First-Quarter 2013 Financial Results

CAMBRIDGE, Mass., April 30, 2013 (GLOBE NEWSWIRE) --

about 25 days ago 

Aegerion Pharmaceuticals, Inc. Logo

Aegerion Pharmaceuticals, Inc.

Anne VanLent Appointed to Aegerion Pharmaceuticals' Board of Directors

CAMBRIDGE, Mass., April 29, 2013 (GLOBE NEWSWIRE) --

about 26 days ago 

Aegerion Pharmaceuticals, Inc. Logo

Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces Presentation at the Needham Healthcare Conference

CAMBRIDGE, Mass., April 25, 2013 (GLOBE NEWSWIRE) --

about 29 days ago 

Aegerion Pharmaceuticals, Inc. Logo

Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals to Announce First Quarter 2013 Financial Results on Tuesday, April 30

CAMBRIDGE, Mass., April 16, 2013 (GLOBE NEWSWIRE) --

about 39 days ago 

Aegerion Pharmaceuticals, Inc. Logo

Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program

CAMBRIDGE, Mass., April 3, 2013 (GLOBE NEWSWIRE) --

about 51 days ago 

Aegerion Pharmaceuticals, Inc. Logo

Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces Fourth-Quarter and Year-End 2012 Financial Results

CAMBRIDGE, Mass., March 6, 2013 (GLOBE NEWSWIRE) --

about 80 days ago 

Aegerion Pharmaceuticals, Inc. Logo

Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program

CAMBRIDGE, Mass., March 5, 2013 (GLOBE NEWSWIRE) --

about 80 days ago 

Showing 1-10 of about 100 articles.

  • 1
  • 2
  • ...
  • 10
  • Next »
Easily Send & Share Press Releases
  • Home
  • Newsroom
  • RSS Feeds
  • Send Releases
  • Regulatory Filings
  • Privacy Policy
© 2013 GlobeNewswire, Inc. All Rights Reserved.
About Us
GlobeNewswire, a NASDAQ OMX company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Contact Us
Corporate Headquarters
5200 W. Century Blvd.
Suite 890
Los Angeles, CA 90045
Phone: (800) 307-6627
Fax: (800) 307-3567
European Headquarters
Nikolaj Plads 6
P.O. Box 1040
Copenhagen, Denmark
Phone: +45 33 77 03 77
Fax: +45 33 12 86 13